2 completed, 1 terminated. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Part 2: new trials by email Literature Review of Part 2 trials Research Report on Part 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Drug Interaction Study of ZYN002 Transdermal Gel and Probe Substrates Part 1, Part 2 - Drug Interaction | Phase 1 | Completed | Harmony Biosciences Management, Inc. | 29 | 2025-06-06 | 2026-02-09 |
| Phase 1/Phase 2a Study of AERO-007 Inhalation Solution, a Nebulized LABA/LAMA Combination for Maintenance Treatment of COPD AERO-001, AERO-002, AERO-007 - COPD | Phase 1 / Phase 2 | Completed | AeroRx Therapeutics Inc. | 24 | 2025-01-15 | 2025-08-01 |
| A Study in Patients With Advanced Breast Cancer Part 1, Part 2, Part 3 - HER2-negative Breast Cancer, Advanced Breast Cancer | Phase 1 | Terminated | Sun Pharma Advanced Research Company Limited | 9 | 2022-05-20 | 2023-05-22 |
Pulmonary Disease, Chronic Obstructive (1) · Respiratory Aspiration (1)
AeroRx Therapeutics Inc. (1) · Harmony Biosciences Management, Inc. (1) · Sun Pharma Advanced Research Company Limited (1)
Australia (1) · India (1) · United Kingdom (1) · United States (1)
Dave Singh, MD (1) · Kristen Bzdek, MD (1) · Thomas Polasek, MD, PhD (1)